Skip To Main Content
Michelle J Groome on Muck Rack

Michelle J Groome

As seen in: Nature, The Conversation, Independent Online, The Lancet, TimesLIVE, AllAfrica, Eyewitness News, Modern Ghana, Down To Earth, Global Biodefense and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michelle J

Contact Michelle J, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

How Gavi support for RSV immunisation will advance health equity

|
By Louis Bont, Michelle J Groome, Ruth A Karron
| The Lancet Verified
aCentre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya bWilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht University, Utrecht 3584EA, Netherlands cSouth African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa dDepartment of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore,...
Open in Who Shared Issue with article?

Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa - Nature Communications

|
By Nicole Wolter, Waasila Jassat, Richard Welch, Harry Moultrie, Michelle J Groome, Daniel Gyamfi Amoako, Josie Everatt, Jinal N. Bhiman, Cathrine Scheepers, Mignon du Plessis, Arshad Ismail, Nei-yuan Hsiao, Anne von Gottberg
| Nature Verified
We performed a data linkage study, using methods that have been previously described in detail6. Briefly, we linked national individual-level data from three sources: (i) national COVID-19 case data, (ii) SARS-CoV-2 laboratory test data for public sector laboratories and one large private sector laboratory, and (iii) DATCOV, which is an active surveillance system for COVID-19 hospital admissions in South Africa.
Open in Who Shared Issue with article?

Four ways SA's latest COVID surge is different – Bhekisisa

|
By Michelle J Groome, Juliet Pulliam, Sheetal Prakash Silal
| Bhekisisa
Future upticks in COVID cases are unlikely to overwhelm South Africa’s health system – unless a new, harsher variant arises here or spreads to the country from somewhere else. What’s more, the current spike in cases hasn’t translated into more people in hospitals or an increase in deaths. Nonetheless, these experts say that there are still some figures people can use to gauge when they should be more careful. Confirmed cases of SARS-CoV-2 have been increasing in South Africa in recent weeks.
Open in Who Shared Issue with article?
See all 29 licensed articles (31 Total)